Entrada Therapeutics (TRDA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov7

Entrada Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 1.614 M (forecast USD 8.621 M), actual EPS USD -1.0644 (forecast USD -0.99)

04:00

Entrada Therapeutics released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 24.12 M, actual EPS USD -2.5294

04:00

Aug7

Entrada Therapeutics released FY2025 Semi-Annual earnings on August 6 (EST), actual revenue USD 22.51 M, actual EPS USD -1.47

03:00

Entrada Therapeutics released FY2025 Q2 earnings on August 6 (EST), actual revenue USD 1.95 M (forecast USD 8.167 M), actual EPS USD -1.0426 (forecast USD -0.8475)

03:00

Jul11

5AM Ventures Reports Sale of Entrada Therapeutics Common Stock

21:26

Jun11

Entrada Therapeutics Held 2025 Annual Shareholders' Meeting

20:09